KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Equity (2016 - 2025)

Historic Return on Equity for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to 1.72%.

  • AbbVie's Return on Equity fell 25200.0% to 1.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.72%, marking a year-over-year decrease of 25200.0%. This contributed to the annual value of 0.62% for FY2024, which is 2700.0% up from last year.
  • Latest data reveals that AbbVie reported Return on Equity of 1.72% as of Q3 2025, which was down 25200.0% from 5.7% recorded in Q2 2025.
  • AbbVie's Return on Equity's 5-year high stood at 5.7% during Q2 2025, with a 5-year trough of 1.72% in Q3 2025.
  • Moreover, its 5-year median value for Return on Equity was 0.71% (2022), whereas its average is 0.86%.
  • Within the past 5 years, the most significant YoY rise in AbbVie's Return on Equity was 49800bps (2025), while the steepest drop was -25200bps (2025).
  • Quarter analysis of 5 years shows AbbVie's Return on Equity stood at 0.8% in 2021, then fell by -11bps to 0.71% in 2022, then plummeted by -39bps to 0.43% in 2023, then surged by 110bps to 0.91% in 2024, then plummeted by -290bps to 1.72% in 2025.
  • Its last three reported values are 1.72% in Q3 2025, 5.7% for Q2 2025, and 1.74% during Q1 2025.